Andrea Cercek, MD - Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p></p>For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JXZ865. CME/MOC/AAPA/IPCE credit will be available until November 7, 2025.</p></p>Accelerating Personalized Care in CRC: The Prominent Role of Predictive Biomarkers and Immunotherapy Platforms in Early and Advanced Disease</p></p> In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p></p><strong>Support<br /></strong>This educational activity is supported by an independent medical education grant from GSK.</p></p>Disclosure information is available at the beginning of the video presentation.

00:39:31

Andrew J. Wagner, MD, PhD - Building the Alliance in Dedifferentiated Liposarcoma: Integrating Personalized, Multidisciplinary Care With Innovative MDM2 Antagonists in Advanced Disease

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p></p>For the full presentation, downloadable Practice Aids, slides, and complete CME/CC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ADF865. CME/CC/NCPD/CPE/AAPA/IPCE credit will be available until November 10, 2025.</p></p>Building the Alliance in Dedifferentiated Liposarcoma: Integrating Personalized, Multidisciplinary Care With Innovative MDM2 Antagonists in Advanced Disease</p></p> In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Sarcoma Alliance for Research through Collaboration. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p></p><strong>Support<br /></strong>This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.</p></p>Disclosure information is available at the beginning of the video presentation.

00:59:39

Kassandra August-Marcucio, DNP, APRN, ACNP-BC, SANE, Grace Cullen, DNP, FNP-BC, AOCNP, PMGT-BC, FPCN - Nurse-Led Strategies for Optimizing PARP Inhibitors in Veterans With Prostate Cancer: Genomic Testing and Practical Care Delivery

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p></p>For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA information, and to apply for credit, please visit us at PeerView.com/EFK865. NCPD/ILNA credit will be available until November 29, 2025.</p></p>Nurse-Led Strategies for Optimizing PARP Inhibitors in Veterans With Prostate Cancer: Genomic Testing and Practical Care Delivery</p></p> In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p></p><strong>Support<br /></strong>This activity is supported by independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.</p></p>Disclosure information is available at the beginning of the video presentation.

00:55:47

Irl Hirsch, MD, MACP - The New Normal: Digital Technologies for People Living With Insulin-Treated Type 2 Diabetes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p></p>For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UHT865. CME/NCPD/AAPA credit will be available until October 31, 2025.</p></p>The New Normal: Digital Technologies for People Living With Insulin-Treated Type 2 Diabetes</p></p> In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p></p><strong>Support<br /></strong>This activity is supported by an educational grant from Novo Nordisk Inc.</p></p>Disclosure information is available at the beginning of the video presentation.

00:56:26

Sharon Cohen, MD, FRCPC / Erik Musiek, MD, PhD - Using APOE as a Key in Alzheimer’s Disease Treatment: Unlocking the Amyloid-Targeting Therapy Risk–Benefit Conundrum

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p></p>For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WZX865. CME/MOC/NCPD/AAPA/IPCE credit will be available until November 16, 2025.</p></p>Using <em>APOE</em> as a Key in Alzheimer’s Disease Treatment: Unlocking the Amyloid-Targeting Therapy Risk–Benefit Conundrum</p></p> In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p></p><strong>Support<br /></strong>This activity is supported by an educational grant from Lilly.</p></p>Disclosure information is available at the beginning of the video presentation.

01:00:52

Guillermo E. Umpierrez, MD, CDE, FACP, FACE - Prioritizing Weight Management as a Primary Goal in People With Type 2 Diabetes: An Office Hours Activity

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p></p>For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/RWC865. CME/NCPD/AAPA credit will be available until November 29, 2025.</p></p>Prioritizing Weight Management as a Primary Goal in People With Type 2 Diabetes: An Office Hours Activity</p></p> In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p></p><strong>Support<br /></strong>This activity is supported by an educational grant from Lilly.</p></p>Disclosure information is available at the beginning of the video presentation.

00:30:47

James F. Howard Jr., MD, FAAN / Nicholas J. Silvestri, MD, FAAN - Steering Away From Steroids in Myasthenia Gravis Management: The Role of FcRn Inhibitors in the Current Treatment Paradigm

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p></p>For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JDS865. CME credit will be available until November 16, 2025.</p></p>Steering Away From Steroids in Myasthenia Gravis Management: The Role of FcRn Inhibitors in the Current Treatment Paradigm</p></p> In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p></p><strong>Support<br /></strong>This activity is supported by an educational grant from argenx US, Inc.</p></p>Disclosure information is available at the beginning of the video presentation.

01:04:03

Meghan C. Thompson, MD - Building Resilient Care Communities for R/R CLL: Collaborative Sequential Approaches in an Era of Innovative Options

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p></p>For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CYC865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until November 23, 2025.</p></p>Building Resilient Care Communities for R/R CLL: Collaborative Sequential Approaches in an Era of Innovative Options</p></p> In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p></p><strong>Support<br /></strong>This activity is supported by an educational grant from Lilly.</p></p>Disclosure information is available at the beginning of the video presentation.

01:04:53

Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC - Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p></p>For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.</p></p>Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia</p></p> In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p></p><strong>Support<br /></strong>This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.</p></p>Disclosure information is available at the beginning of the video presentation.

00:59:00

April W. Armstrong, MD, MPH - Staying on Target Against Moderate to Severe Psoriasis: Strategies for Achieving Sustained Benefits Through TYK2 Inhibition

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p></p>For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RJG865. CME/MOC/AAPA/IPCE credit will be available until October 22, 2025.</p></p>Staying on Target Against Moderate to Severe Psoriasis: Strategies for Achieving Sustained Benefits Through TYK2 Inhibition</p></p> In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p></p><strong>Support<br /></strong>This activity is supported by an educational grant from Bristol Myers Squibb.</p></p>Disclosure information is available at the beginning of the video presentation.

00:48:16